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H I G H L I G H T S
• BBF2H7-derived small peptide fragments (BSP fragments) have high hydrophobicity.• BSP fragments accelerate fibril formation of amyloid β peptide.• Cytotoxicity of amyloid β peptide are enhanced by co-incubation with BSP fragments.• BSP fragments could modulate pathogenicity of Alzheimer’s disease.





A B S T R A C T
Aggregation, fibril formation, and deposition of amyloid β (Aβ) protein are believed to be the central patho-
geneses of Alzheimer’s disease (AD). Numerous studies have shown that fibril formation is promoted by pre-
formed seeds at the beginning of the aggregation process. Therefore, aggregated molecules that promote fi-
brillization of Aβ protein as seeds could affect the pathology. We recently found that approximately 40 amino
acid hydrophobic peptides, BBF2H7-derived small peptide (BSP) fragments, are generated via intramembranous
cleavage under endoplasmic reticulum (ER) stress conditions. Interestingly, similar to Aβ protein, the fragments
exhibit a high aggregation propensity and form fibril structures. It has been noted that ER stress is involved in
the pathogenesis of AD. In this study, we examined the effect of BSP fragments on aggregation and cytotoxicity
of Aβ1–40 protein, which is generated as a major species of Aβ protein, but has a lower aggregative property than
Aβ1–42 protein. We demonstrated that BSP fragments promote aggregation of Aβ1–40 protein. Aggregates of
Aβ1–40 protein mediated by BSP fragments also exhibited potent neurotoxicity. Our findings suggest the possi-
bility that BSP fragments affect accumulation of Aβ proteins and are involved in the pathogenesis of AD.
1. Introduction
Alzheimer’s disease (AD) is the most prevalent form of dementia. AD
is characterized by misfolding, fibrillization, and accumulation of the
amyloid β (Aβ) peptide, which results in the formation of extracellular
senile plaques as a pathological hallmark (Masters et al., 1985). A
37–43 amino acid hydrophobic Aβ peptide is generated by sequential
proteolytic processing of the amyloid precursor protein (APP) (Haass
et al., 2012). APP is a type-I transmembrane protein with its N-terminus
within the lumen/extracellular space and C-terminus within the cy-
tosol. In the first step of the sequential proteolysis, β-secretase cleaves
APP at the N-terminal luminal domain. This process removes a large
part of the ectodomain of APP and generates a membrane-retained C-
terminal fragment (CTF). CTF is processed further to Aβ and the APP
intracellular domain by γ-secretase that cleaves within the transmem-
brane region. Aβ is located between the β- and γ-secretase cleavage
sites. Heterogenous proteolysis of CTF by γ-secretase principally gen-
erates 40 and 42 amino acid peptides, Aβ1–40 and Aβ1–42, respectively.
Although the relative abundance of Aβ1–40 (~90%) in the brain is much
greater than that of Aβ1–42 (~10%), amyloid plaques consist pre-
dominantly of Aβ1–42 in patients with AD (Iwatsubo et al., 1994; Roher
et al., 1993). Aβ1–42 is more hydrophobic than Aβ1–40 and displays a
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Fig. 1. BSP fragments promote fibrillization of amyloid β1–40. (A) Schematic representation of the formation of amyloid fibrils accelerated by an Aβ1–42 seed. (B)
Negative-stain transmission electron microscopy micrographs of amyloid fibrils increased by addition of Aβ1–42 or BSP fragments. Mixtures of 5 µM Aβ1–40 and
0.15 µM Aβ1–42, BSP fragments, or 0.3 µM Apelin-36, mixture of 0.3 µM Aβ1–42 and 0.3 µM BSP fragments, or each peptide alone were incubated for 48 h. After
incubation, the peptides were stained with uranyl acetate. Scale bar: 200 nm. (C) Length, width, and periodicity of fibrils derived from a mixture of Aβ1–40 and
Aβ1–42, or Aβ1–40 and BSP fragments (mean ± SD, n= 5). *P < 0.05, **P < 0.01 relative to a mixture of Aβ1–40 and Aβ1–42; significance was calculated by the
Student’s t-test. (D) Amounts of fibrils derived from a mixture of Aβ1–40 and Aβ1–42 or Aβ1–40 and BSP fragments (mean ± SD, n= 30). *P < 0.05 relative to Aβ1–40
alone; significance was calculated by Dunnett’s method. (E) Time course of the length of fibrils derived from a mixture of Aβ1–40 and Aβ1–42, or Aβ1–40 and BSP
fragments (mean ± SD, n=5). *P < 0.05, **P < 0.01 and ***P < 0.001 relative to a mixture of Aβ1–40 and BSP fragments at a same time point; significance was
calculated by the Student’s t-test.
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considerably higher propensity to form neurotoxic aggregates. Most
familial AD-related mutations found within the transmembrane region
of APP increase the Aβ1–42/Aβ1–40 ratio (Weggen and Beher, 2012).
Thus, Aβ1–42 and its aggregation are believed to be the cause of AD
pathogenesis (Selkoe, 2011).
Aβ aggregation is promoted in a prion-like manner by the presence
of misfolded Aβ seeds that act as a core structure of amyloid fibrils
(Walker and Jucker, 2015). Local overproduction of Aβ1–42 aggregates
could induce fibrillization of abundant and normally soluble Aβ1–40.
This concept is supported by several animal models by showing ac-
celerated Aβ pathology in host organisms after intracerebral injection
of brain homogenates containing Aβ aggregates (Kane et al., 2000;
Meyer-Luehmann et al., 2006). Additionally, another fibril-forming
peptide, amylin, promotes fibrillization and deposition of Aβ in AD
model mice (Moreno-Gonzalez et al., 2017). Hence, other aggregative
molecules could affect aggregation and deposition of Aβ and modify the
pathogenesis of AD.
Several studies have indicated that endoplasmic reticulum (ER)
stress is closely related to AD pathology. Numerous studies have re-
ported that various ER stress markers, such as heat shock protein 70
(also known as BiP), phosphorylated PKR-like endoplasmic reticulum
kinase, phosphorylated inositol-requiring enzyme 1, and phosphory-
lated eukaryotic translation initiation factor 2-α, are increased in post-
mortem brain samples from patients with AD (Hetz and Saxena, 2017).
Attenuation of ER stress by treatment with a chemical chaperone, 4-
phenylbutyrate, significantly reduced the number of plaques in the
hippocampus and reversed cognitive deficits in AD mouse models,
which indicated a causal link between ER stress and neurodegeneration
(Ricobaraza et al., 2011; Wiley et al., 2011). However, the precise
mechanisms underlying ER stress and the pathogenesis of AD are not
completely understood.
Recently, we found that novel small hydrophobic peptides, namely
BBF2H7-derived small peptide fragments (BSP fragments), are pro-
duced in response to ER stress (Matsuhisa et al., 2020). BBF2H7, one of
the OASIS family members, is a type-II transmembrane protein that is
highly expressed in neurons, chondrocytes, and certain tumor tissues
(Iwamoto et al., 2015; Kondo et al., 2007; Saito et al., 2009, 2014). The
N-terminal segment contains a basic leucine zipper domain and projects
into the cytosol. This is followed by a 20 amino acid transmembrane
domain and 123 amino acid C-terminal domain that projects into the
ER lumen. When unfolded proteins accumulate in the ER, BBF2H7
translocates from the ER to Golgi apparatus. In the Golgi, BBF2H7 is a
substrate for two proteases, site-1 protease (S1P) and site-2 protease
(S2P). S1P cleaves BBF2H7 in the luminal region. The N-terminal do-
main of BBF2H7 remains attached to the membrane through the
transmembrane segment. The transmembrane region of this segment is
then cleaved by S2P. This intramembranous cleavage releases the N-
terminal fragments and 40–50 amino acid BSP fragments (Kondo et al.,
2007; Matsuhisa et al., 2020). Although the cleavage enzymes are dif-
ferent, BSP fragments are also released by a two-step cleavage process
in the luminal and transmembrane domains of the precursor, which is
similar to Aβ. Additionally, BSP fragments exhibit a high aggregation
propensity and form fibril-like structures (Matsuhisa et al., 2020). Thus,
we hypothesized that hyper and prolonged production of BSP fragments
by ER stress may affect aggregation and neurotoxicity of Aβ, which
modifies AD pathogenesis.
In this study, we examined the effects of BSP fragments on fi-
brillization and cytotoxicity of Aβ. Furthermore, we investigated the
degradation pathway of BSP fragments. Accordingly, we found that
coincubation of BSP fragments promotes fibrillization and cytotoxicity
of Aβ1–40.
2. Results
2.1. BSP fragments accelerate fibril formation of Aβ1–40
Misfolded Aβ1–42 acts as a core structure and accelerates fibriliza-
tion of Aβ1–40 (Fig. 1A). First, we analyzed the effect of BSP fragments
on fibrillization of Aβ1–40. An extremely high concentration of Aβ1–40
forms fibrils. No fibrils were observed at 5 µM Aβ1–40 in our titration
experiments. To avoid fibrilization of Aβ1–40 itself, we used 5 µM
Aβ1–40. Accordingly, 5 μM Aβ1–40 was mixed with 0.3 μM Aβ1–42,
0.3 μM BSP fragments, or 0.3 μM Apelin-36 and incubated at 37 °C for
48 h. Apelin-36 is a hydrophilic peptide and used as a negative control
(Matsuhisa et al., 2020). Next, precipitates were observed by trans-
mission electron microscopy (TEM) (Fig. 1B). TEM analysis showed that
Aβ1–40 alone did not form fibrillar structures. However, fibrils were
observed after addition of Aβ1–42, as described in a previous study
(Tamaoka et al., 1994). Notably, BSP fragments accelerated fibrilliza-
tion of Aβ1–40, whereas Apelin-36 did not. We did not detect 0.3 μM
Aβ1–42 or 0.3 μM BSP fragments in aggregates. Next, we analyzed the
effects of BSP fragments on fibrilization of Aβ1–42. We examined fibrils
in the incubated mixture of 0.3 μM Aβ1–42 and 0.3 μM BSP fragments
because Aβ1–42 alone formed fibrils at the concentration higher than
0.3 μM. In contrast to Aβ1–40 fibrilization, Aβ1–42 fibrils were not ob-
served after addition of BSP fragments. Aβ1–42 fibrilization might not be
affected by addition of BSP fragments because of fast aggregation of
Aβ1–42 as well as that of BSP fragments. We found that BSP fragment-
promoted Aβ1–40 fibrils were longer (approximately 2,250 nm) and
wider (approximately 16 nm) than Aβ1–40 fibrils mediated by Aβ1–42
(length: approximately 960 nm; width: approximately 8 nm) (Fig. 1C).
BSP fragments also increased the length between periodical turns in
Aβ1–40 fibrils compared with Aβ1–42. Although the reason for these
differences in acceleration of fibril formation of Aβ1–40 by BSP frag-
ments and Aβ1–42 remains unclear, it is nonetheless apparent that BSP
fragments have the potential to change the characteristics of Aβ1–40
fibrils. We also examined dose-dependency of Aβ1–42 and BSP frag-
ments for acceleration of Aβ1–40 fibrilization (Fig. 1D). Fibril number
was increased by addition of 0.075, 0.15, and 0.3 µM Aβ1–42 in a dose-
dependent manner. Addition of BSP fragments also dose-dependently
increased fibrils from 0.075 µM to 0.15 µM. Fibrils were not increased
by addition of 0.3 µM BSP fragments compared with 0.15 µM BSP
fragments. Next, we examined the time course of Aβ1–40 fibril formation
accelerated by Aβ1–42 and BSP fragments (Fig. 1E). The length of Aβ1–40
and Aβ1–42 fibrils was linearly increased from 3 to 48 h after incubation.
Fibrils of Aβ1-40 mixed with BSP fragments were shorter than those of
the mixture of Aβ1–40 and Aβ1–42 from 3 to 24 h. However, BSP frag-
ment-promoted Aβ1–40 fibrils longer than Aβ1–40 fibrils mediated by
Aβ1–42 at 48 h. BSP fragments might strongly accelerate fibril formation
of Aβ1–40 between 24 and 48 h after incubation. Collectively, these data
suggest that co-existence of BSP fragments promotes fibrillization of
Aβ1–40.
2.2. BSP fragments promote cytotoxicity of Aβ
Next, we analyzed the effect of BSP fragments on cytotoxicity of
Aβ1–40 using synthetic peptides and human neuroblastoma SK-N-SH
cells. Aβ1–40 at 5 μM was mixed with 0.15 μM Aβ1–42, 0.15 μM BSP
fragments, or 0.3 μM Apelin-36 and incubated at 37 °C for 24 h. The
incubated peptides were then applied to SK-N-SH cells for 48 h (Fig. 2A,
B). Cells treated with 5 μM Aβ1–40 alone did not show visible mor-
phological changes. However, 0.15 μM Aβ1–42 slightly decreased the
number of cells. Aβ1–40 preincubated with Aβ1–42 exhibited more potent
cytotoxicity than either Aβ peptide alone, as described previously
(Sowade and Jahn, 2017). Interestingly, almost all cells shrank after
treatment with Aβ1–40 coincubated with BSP fragments. A large pro-
portion of cells were intact in the presence of 0.15 μM preincubated BSP
fragments alone. Morphological changes were not observed in cells
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treated with a mixture of Aβ1–40 and Apelin-36. Taken together, these
results indicate that BSP fragments enhance the cytotoxicity of Aβ1–40.
2.3. BSP fragments also exhibit cytotoxicity
BSP fragments have similar characteristics to those of Aβ.
Accordingly, BSP fragments may directly cause cytotoxicity. To in-
vestigate the potential contribution of BSP fragments to neurodegen-
eration, we examined their cytotoxicity. BSP fragments were pre-
incubated at 37 °C for 24 h and then applied to SK-N-SH cells for 48 h. A
large proportion of cells were intact, but slightly decreased in number
in the presence of 5 μM preincubated BSP fragments (Fig. 3A, B). The
cells shrank after addition of 10 or 20 μM fragments. Moreover, treat-
ment with the above 10 μM preincubated peptides significantly de-
creased cell survival. These results indicate that aggregated BSP frag-
ments themselves are cytotoxic molecules.
2.4. BSP fragments are degraded through the lysosomal degradation
pathway
Next, we analyzed the expression levels of full length and N-term-
inal fragments of BBF2H7, BSP fragments, and ER stress markers in SK-
N-SH cells transfected with BBF2H7 under ER stress conditions induced
by ER stressor thapsigargin (Tg) by Western blotting. In mammalian
cells, three major ER stress transducers have been well established:
PKR-like endoplasmic reticulum kinase, inositol-requiring enzyme 1,
and ATF6 (Harding et al., 1999; Tirasophon et al., 1998; Yoshida et al.,
2000). These transducers induce expression of C/EBP homologous
protein (CHOP), spliced form of X-box binding protein 1 (XBP1s), and
BiP/Grp78, respectively (Ron and Walter, 2007). Therefore, we ana-
lyzed the expression levels of these proteins as ER stress markers. BiP
was increased from 12 to 24 h after treatment with Tg (Fig. 4A).
Treatment with Tg induced expression of CHOP and XBP1s at 6 h,
which decreased gradually from 12 to 24 h. The 80 kDa full length
BBF2H7 and 60 kDa N-terminal fragments were elevated gradually
from 6 h after treatment, which indicated cleavage of BBF2H7. BSP
fragments were also increased after treatment with Tg for 12 h, which
followed the increase in N-termini. These data indicate that BSP frag-
ments are produced after induction of CHOP and XBP1s, and that
production of BSP fragments might be sustained under ER stress con-
ditions. Furthermore, we investigated the degradation pathway of BSP
fragments. SK-N-SH cells transfected with BBF2H7 were treated with Tg
with or without proteasome inhibitor MG132 or lysosomal inhibitor
bafilomycin A1 (BafA1). Next, we performed Western blotting using
anti-BBF2H7 N-terminus and -BSP fragment antibodies. Full length and
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Fig. 2. BSP fragments enhance cytotoxicity of amyloid β1–40. (A) Representative phase-contrast micrographs. SK-N-SH cells were cultured for 48 h in the presence of
preincubated mixtures of 5 µM Aβ1–40 and 0.15 µM Aβ1–42, BSP fragments, or 0.3 µM Apelin-36, or each peptide alone. (B) The number of viable cells at 48 h after
treatment with preincubated peptides or a mixture of peptides. Results are presented as mean relative cell counts of surviving cells compared with the untreated
group ± SD (n = 3). ***P < 0.001; significance was calculated by the Tukey-Kramer method.
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Fig. 3. BSP fragments exhibit cytotoxicity. (A) Representative phase-contrast micrographs. SK-N-SH cells were cultured for 48 h in the presence of 0.15, 0.3, 0.6,
1.25, 2.5, 5, 10, and 20 μM preincubated BSP fragments. (B) The number of viable cells at 48 h after treatment with preincubated BSP fragments. Results are
presented as mean relative cell counts of surviving cells compared with the untreated group ± SD (n = 3). ***P < 0.001 relative to control; significance was
calculated by Dunnett’s method.
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treated cells (Fig. 4B). BSP fragments appeared at 12 h after treatment.
Treatment of cells with Tg and MG132 resulted in a dramatic increase
in BSP fragments. Levels of full length BBF2H7 and N-terminal frag-
ments were also elevated in these cells. BBF2H7 is degraded by the
ubiquitin–proteasome system under normal conditions (Kondo et al.,
2012). Stabilization of full length BBF2H7 by inhibition of the protea-
some leads to an increase in the N-terminal and BSP fragments. Co-
treatment with BafA1 did not increase the levels of N-terminal frag-
ments compared with Tg-treated cells, which indicated that cleavage of
BBF2H7 was not affected. However, levels of BSP fragments were in-
creased significantly by lysosomal inhibition. These data indicate that
BSP fragments were degraded in lysosomes. Additionally, we performed
immunofluorescence staining of SK-N-SH cells transfected with BBF2H7
(Fig. 4B). Immunoreactivities of BSP fragments did not overlap with
those of lysosome-associated membrane protein 2 (LAMP2; a lysosomal
marker) in cells treated with Tg. BSP fragments accumulated in LAMP2-
positive lysosomes after inhibition of lysosomal functions by cotreat-
ment with BafA1. The anti-BSP fragment antibody used in this study
also detects full length BBF2H7. BSP fragments were not produced from
BBF2H7 mutated in its S1P recognition site (BBF2H7S1Pmut.; RNLL to
ANLV) (Matsuhisa et al., 2020). Then, we analyzed the im-
munoreactivities of BSP fragments in SK-N-SH cells transfected with
BBF2H7S1Pmut.. The signals of BSP fragments did not overlap with those
of LAMP2 in cells expressing BBF2H7S1Pmut. in spite of treating the cells
with Tg and BafA1. Therefore, these findings suggest that BSP frag-
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Fig. 4. BSP fragments are degraded via the lysosomal pathway. (A) Western blotting of BBF2H7 N-terminal fragments, BSP fragments and ER stress markers BiP,
spliced form of XBP1 (XBP1s) and CHOP in SK-N-SH cells expressing BBF2H7. Cells were treated with 1 µM thapsigargin (Tg) for the indicated times. Lysates were
subjected to Western blotting using anti-BBF2H7 N-terminus, anti-KDEL (to detect BiP), anti-XBP1s, and anti-CHOP antibodies. To detect BSP fragments, lysates were
immunoprecipitated using an anti-BSP fragment antibody followed by Western blotting with the same antibody. (B) Western blotting of BBF2H7 N-terminal and BSP
fragments in SK-N-SH cells expressing BBF2H7. Cells were treated with 1 µM Tg alone or together with 10 µM MG132 or 100 nM bafilomycin A1 (BafA1) for the
indicated times. (C) Immunofluorescence staining of BSP fragment (Green) and lysosome-associated membrane protein-2 (LAMP2; Red) in SK-N-SH cells expressing
BBF2H7 or BBF2H7S1Pmut.. Cells were treated with 1 µM Tg alone or together with 100 nM BafA1 for 12 h. Right most panels show higher magnification images in the
boxes shown in merged panel. Scale bars: 10 µm (BSP fragment, LAMP2, and lower magnification merged panels) and 1 µm (higher magnification images).
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3. Discussion
We have shown that BSP fragments promote fibrillization of Aβ1–40
(Fig. 1B). Formation of amyloid fibrils is described by the seeding-nu-
cleation polymerization model (Jarrett and Lansbury, 1993). First,
monomeric Aβ is incorrectly folded and forms small oligomeric ag-
gregates. The aggregates act as “seeds” in fibrilization of Aβ. This ag-
gregation process is thermodynamically unfavorable. Then, the seeds
rapidly recruit and misfold the other Aβ monomers. The misfolded Aβ
monomers bind to the seeds and form fibrils. Formation of seeds is a
rate-limiting step in fibrillization. Several studies have shown that the
aggregates derived from different proteins such as prion protein, tau,
and α-synuclein act as preformed seeds, which accelerate fibril for-
mation of Aβ (Morales et al., 2013). It has been proposed that the
amyloid structure promotes misfolding of other amyloidogenic proteins
(Makarava and Baskakov, 2012). Our previous study revealed that BSP
fragments easily aggregate and form fibril structures similar to Aβ and
other amyloidogenic proteins (Matsuhisa et al., 2020). Aggregated BSP
fragments could recruit monomeric Aβ and change its conformation to
a misfolded structure as preformed seeds, which accelerates fibril for-
mation.
Amyloid fibrils are commonly twisted and exhibit periodical turns.
TEM analysis revealed the twisted structures of Aβ1–40 fibrils formed by
coincubation with BSP fragments (BSP-Aβ1–40 fibrils) (Fig. 1C). The
length between turns was longer than that of fibrils mediated by Aβ1–42
(Aβ1–42-Aβ1–40 fibrils). Previous studies have shown that morphological
differences of Aβ fibrils correlate with their neurotoxicity (Meyer-
Luehmann et al., 2006; Petkova et al., 2005; Stöhr et al., 2012). Aβ
fibrils with a short distance between turns exhibit low cytotoxicity
compared with those with a long distance between turns (Kumar et al.,
2015). The length between turns of BSP-Aβ1–40 fibrils was longer than
those of Aβ1–42-Aβ1–40 fibrils and Aβ1–42 fibrils (Matsuhisa et al., 2020).
Cell survival assays showed that BSP-Aβ1–40 fibrils exhibited more po-
tent cytotoxicity than Aβ1–42-Aβ1–40 fibrils (Fig. 2B). Taken together,
these findings suggest that BSP fragments affect the cytotoxicity of Aβ
fibrils by modulating their periodical turns.
BSP fragments themselves also decreased neuronal cell viability
(Fig. 3A, B). Although the cytotoxic mechanisms of Aβ are still not fully
determined, some researchers have proposed that Aβ cause membrane
damage through the formation of stable pores on the membrane, which
result in severe neurotoxicity (Kotler et al., 2014). Other amyloidogenic
proteins including 37 amino acid peptide amylin also exhibit cyto-
toxicity through the same mechanism (Cheng et al., 2013). Hydro-
phobic interactions between amyloidogenic proteins including Aβ and
membranes is essential for their cytotoxicity. A previous study has
suggested that the fibril-forming propensity is partly related to the as-
sembly of Aβ within the membrane (Yip and McLaurin, 2001). BSP
fragments also contain a highly hydrophobic N-terminal region and
form a fibril structure similar to Aβ (Matsuhisa et al., 2020). Therefore,
it is possible that BSP fragments disrupt cell membrane integrity and
cause cell death via an interaction between their N-terminal hydro-
phobic region and membranes. Additionally, Aβ has been reported to
exhibit cytotoxicity through production of reactive oxygen species
(ROS) (Uttara et al., 2009). Aβ binds to metal ions, such as Cu, Zn, and
Fe, via the imidazole ring of His residues (Cheignon et al., 2018). The
Aβ-metal complex plays an important role in production of ROS. An-
other amyloidogenic peptide, amylin, also binds to Cu ions via the His
residue and the complex produces ROS (Seal and Dey, 2018). BSP
fragments contain a His residue in the luminal region. Taken together,
another possible cytotoxic mechanism of BSP fragments is that the
fragments form a complex with metal ions via the His residue and
produce ROS, which results in cell death.
BSP fragments accumulate and are metabolically degraded in the
lysosome (Fig. 4). Many previous investigations have found lysosomal
dysfunction in patients with AD (Whyte et al., 2017). It is natural that
BSP fragments accumulate in the lysosome because of impaired
lysosomal degradation in the brain of AD patients. It is known that Aβ
resides at the outer membrane of multivesicular bodies (MVBs) in the
neurons of AD patients (Takahashi et al., 2002). However, it has been
frequently observed that Aβ accumulates in the lysosome of patients
with AD (Zheng et al., 2012). MVBs fuse with the lysosome and then
their contents undergo degradation. Thus, dysfunction of the lysosome
reduces degradation of Aβ, which results in accumulation in the lyso-
some. Lysosomal accumulation of BSP fragments suggests the possibi-
lity that the fragments act as seeds for Aβ fibrils and promote fibril
formation in the lysosome. Therefore, it would be interesting to analyze
the promoting effects of BSP fragments on aggregation of Aβ in vivo.
Interestingly, ER stress markers appeared even in morphologically
healthy neurons of patients in the early stages of AD (Hoozemans et al.,
2009). It has also been reported that the number of neurons containing
phosphorylated PKR-like endoplasmic reticulum kinase, which is an ER
stress sensor, correlates with the pathological stage in post-mortem AD
brains (Hoozemans et al., 2009). These observations indicate that ER
stress is induced in the early stages of AD and the ER stress response is
activated as the disease progresses. Because production of BSP frag-
ments is dependent on ER stress, the fragments could be sustainably
produced in neurons from the early stages of AD. Taken together, it is
conceivable that long term ER stress and lysosomal dysfunction could
synergistically cause overproduction and accumulation of BSP frag-
ments, which accelerates fibril formation of Aβ.
In conclusion, our results suggest the possibility that BSP fragments
promote deposition of Aβ as a core structure of amyloid fibrils. We
believe that our findings may contribute to a better understanding of
the pathological mechanisms and the development of novel therapeutic
approaches of AD. In vivo analyses of the significance of BSP fragments
in AD pathogenesis may provide novel insights into the aggregation
mechanisms of Aβ.
4. Experimental procedure
4.1. Cell culture, reagents, and plasmids
SK-N-SH cells were maintained in α-modified Eagle’s medium
(Gibco, Thermo Fisher Scientific, Waltham, MA, USA) supplemented
with 10% FBS at 37 °C in a humidified atmosphere with 5% CO2. For
cell treatments, 1 μM thapsigargin (Tg) (Wako, Osaka, Japan), 10 μM
MG132 (Wako), and 100 nM bafilomycinA1 (Sigma–Aldrich, St Louis,
MO, USA) were used. The major species of BSP fragment (CFAVAFG-
SFFQGYGPYPSATKMALPSQHPLSEPYTASVVRSRNLL) was synthesized
by Peptide Institute (Osaka, Japan). Aβ1–40 and Aβ1–42 peptides were
purchased from Peptide Institute (Osaka, Japan). Apelin-36 was pur-
chased from Cayman Chemical Company (Ann Arbor, MI, USA).
The pcDNA3.1(+) vector expressing BBF2H7 was constructed pre-
viously (Kondo et al., 2007). Transfection of the expression vector was
performed using ScreenFectA (Wako) in accordance with the manu-
facturer’s protocol. Cells transfected with the expression vector were
used in experiments at 24 h after transfection.
4.2. Protein preparation and Western blotting
Proteins were extracted from cells in cell lysis buffer containing
10 mM Tris-HCl (pH 7.4), 5 mM ethylenediaminetetraacetic acid
(EDTA), 150 mM NaCl, 1% Triton X-100, and protease inhibitor cock-
tail Set V (Wako) at 4 °C. Lysates were incubated on ice for 15 min.
After centrifugation at 15,000×g for 15 min, the protein concentrations
of supernatants were determined using a bicinchoninic acid assay kit
(Thermo Fisher Scientific). Equal amounts of proteins (10 μg) were
subjected to sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS-PAGE). For immunoblotting, the following antibodies were used:
anti-β-actin (1:10000, S5441, Sigma-Aldrich), rabbit polyclonal anti-
BBF2H7-N antibody (1:2000), and rabbit polyclonal anti-BSP fragment
(1:1000) [generated as described previously; (Matsuhisa et al., 2020;
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Saito et al., 2009)]. Samples were subjected to SDS–PAGE followed by
Western blotting.
4.3. Immunofluorescence staining
SK-N-SH cells were grown on coverslips and fixed in 4% paraf-
ormaldehyde for 30 min. After fixation, the cells were permeabilized in
0.1% Triton-X 100 for 5 min, followed by treatment with 10% goat
serum for 60 min. These procedures were performed at room tem-
perature (25 °C). The following antibodies were used: anti-BSP frag-
ment (1:200) and anti-lysosome-associated membrane protein 2
(LAMP2) (1:200, 555803, BD Biosciences, Franklin Lakes, NJ, USA).
Cells were visualized under an FV1000D confocal microscope
(Olympus, Tokyo, Japan).
4.4. Immunoprecipitation
Cells were lysed in cell lysis buffer (10 mM Tris-HCl, pH7.4, 5 mM
EDTA, 150 mM NaCl, 1% Triton X-100, and Protease inhibitor cocktail
set V) for 15 min. Cell lysates were incubated with the anti-BSP frag-
ment antibody (10 μg/1 × 106 cells) and Protein G Agarose Beads
(Merck Millipore, Burlington, MA, USA) at 4 °C overnight. The beads
were then rinsed three times with wash buffer (10 mM Tris-HCl, pH 7.4,
5 mM EDTA, 150 mM NaCl, and 0.1% Triton X-100).
Immunoprecipitates were boiled in Laemmli SDS-PAGE sample buffer,
followed by Western blotting using the anti-BSP fragment (1:1000)
antibody.
4.5. Transmission electron microscopy (TEM) for observation of fibril
formation of peptides
Fibril formation and acceleration of Aβ1–40 fibrillization of BSP
fragments were analyzed using a modification of previously published
protocols (Yanagida et al., 2009). Briefly, synthetic BSP fragments were
dissolved in dimethyl formamide to a concentration of 10 mM. The
resultant peptides were mixed in 50 mM potassium phosphate buffer
(pH 7.4). Diluted peptides were then incubated at 37 °C for 0, 3, 6, 12,
24, or 48 h. After incubation, the peptides were centrifuged for 10 min
at 20,600×g, and precipitated fibrils were analyzed by TEM.
Precipitated fibrils were suspended in 10 μl distilled water. Samples
(3 μl) were applied to carbon-coated Slidefilm SLC-C15 (STEM, Tokyo,
Japan) and incubated for 3 min at room temperature. Excess samples
were absorbed with filter paper, after which an equal volume of uranyl
acetate solution was added. After incubation for 2 min at room tem-
perature, the solution was removed and the grid was dried in air.
Samples were examined under a JEM-1400 transmission electron mi-
croscope (JEOL, Tokyo, Japan).
4.6. Cell survival assay
BSP fragments, Aβ peptides, or a mixture of Aβ, BSP fragments, or
Apelin-36 were preincubated at 37 °C for 24 h in 50 mM potassium
phosphate buffer (pH 7.4). SK-N-SH cells were treated with pre-
incubated peptides for 48 h. The number of surviving cells was counted
on the basis of morphological changes.
4.7. Statistical analysis
Statistical comparisons were made using the Student’s t-test,
Tukey–Kramer method, or Dunnett’s method. The statistical sig-
nificance of differences was determined by P < 0.05.
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